BACKGROUND: Measurement of biomarkers has been incorporated within clinical research
studies of asthma to characterize the population and associate the disease with …

Asthma is a common disease affecting 350 million people worldwide, which is characterized
by airways inflammation and hyperreactivity. Historically diagnosis and treatment have been …

Background: Measurement of fractional nitric oxide (NO) concentration in exhaled breath
(FeNO) is a quantitative, noninvasive, simple, and safe method of measuring airway …

Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

Background The lung microbiome of healthy individuals frequently harbors oral organisms.
Despite evidence that microaspiration is commonly associated with smoking-related lung …

Asthma is a chronic inflammatory disease of the airways, affecting over 350 million people
worldwide and placing a significant burden on healthcare providers and wider society …

The upregulation of nitric oxide (NO) by inflammatory cytokines and mediators in central and
peripheral airway sites can be monitored easily in exhaled air. It is now possible to estimate …

Objective To review the fast-developing topic of assessment of exhaled breath components
to improve the diagnosis and monitoring of respiratory and systemic diseases. Data Sources …

Background It has been claimed that exhaled nitric oxide (FeNO) could be regarded as a
surrogate marker for sputum eosinophil count in patients with asthma. However, the FeNO …

Abstract 3D printers are increasingly run at home. Nanoparticle emissions from those
printers have been reported, which raises the question whether adverse health effects from …